SCHEMBL5193422

SCHEMBL5193422

CC(C)CN1Cc2ccccc2NCC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRPF1 P55201 1/20 0.43
PARP1 P09874 1/20 0.42
BRD4 O60885 1/20 0.41
CREBBP Q92793 1/20 0.41
HSD17B10 Q99714 2/20 0.38
HSD17B3 P37058 1/20 0.38
HTR1A P08908 1/20 0.38
ALOX15 P16050 1/20 0.38
ALDH1A1 P00352 1/20 0.36
PIK3CD O00329 1/20 0.36
PER2 O15055 1/20 0.36
ACHE P22303 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CASP6 P55212 1/20 0.34
MAPK1 P28482 1/20 0.34
P2RX7 Q99572 1/20 0.33
GSK3A P49840 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5191281 0.81 BRPF1 (0.47) BRPF1PARP1BRD4CREBBPHSD17B10
SCHEMBL5194276 0.78 LMNA (0.46) BRPF1BRD4CREBBPHSD17B10HSD17B3
SCHEMBL5196715 0.78 BRPF1 (0.41) BRPF1BRD4CREBBPHSD17B10HSD17B3
SCHEMBL5193610 0.78 BRPF1 (0.44) BRPF1PARP1BRD4CREBBPHSD17B10
SCHEMBL5193417 0.78 GSK3A (0.51) BRPF1PARP1BRD4ALDH1A1ACHE
SCHEMBL5191836 0.77 ITGB3 (0.52) BRPF1BRD4CREBBPHSD17B10HSD17B3
SCHEMBL5193966 0.75 ACHE (0.47) BRPF1PARP1BRD4CREBBPHSD17B10
SCHEMBL14374090 0.75 KDM4E (0.41) BRPF1BRD4CREBBPHSD17B3ALOX15
SCHEMBL5193362 0.74 BRD4 (0.61) BRPF1BRD4CREBBPHSD17B10HSD17B3
SCHEMBL5194517 0.74 KDM4E (0.56) BRPF1BRD4CREBBPHSD17B10HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 US disclosed
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 US disclosed
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-10-04 US disclosed
EP-1813603-A1 AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 EP disclosed
EP-1813603-A1 AROMATIC AMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICAL USES OF BOTH Kissei Pharmaceutical Co., Ltd. (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232594-A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both AVPR2, AVPR1A, AVPR1B BRPF1 4136/4885PARP1 4198/4885BRD4 1592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.